Newsletter Subject

Save Your Spot! | Expert Strategies for DLBCL and FL at ASH 2024

From

primeinc.org

Email Address

cme@email.primeinc.org

Sent On

Thu, Nov 7, 2024 02:42 PM

Email Preheader Text

Learn how to effectively integrate novel therapies into your practice with guidance from leading exp

Learn how to effectively integrate novel therapies into your practice with guidance from leading experts. [PRIME]( [Treatment Crossroads: Diverse Perspectives on Treatment Strategies for Relapsed/Refractory DLBCL and FL]( [REGISTER NOW!]( [Attend Onsite:]( [San Diego, CA Friday, Dec 6, 2024 at 11:00 AM Pacific San Diego Convention Center Room: 6DE 111 W Harbor Drive San Diego, CA 92101 619-525-5000]( [Virtual:]( [1.5 CME/CE | Live Event / Live Webinar]( Join expert faculty at the 2024 ASH Annual Meeting and Exposition for an in-depth look at the latest clinical evidence and practical considerations for treating diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL). This symposium, informed by real-world data on challenges in selecting, sequencing, and integrating novel therapies, will help lymphoma care teams examine the latest evidence, differentiate new CAR T-cell and bispecific antibody therapies, and address barriers to adopting novel therapies. The expert panel will discuss clinical cases, enhanced by interactive polling and live questions from attendees. Don't miss this chance to learn from experts using real-world experiences to improve DLBCL and FL care. This case-based approach will provide strategies for integrating novel therapies to enhance patient care and outcomes. Expert Faculty: Nathan H Fowler, MD Speaker Professor of Medicine (Ret) Department of Lymphoma and Myeloma Division of Cancer Medicine University of Texas MD Anderson Cancer Center Houston, TX Paolo Strati, M.D. Speaker Associate Professor Department of Lymphoma and Myeloma Division of Cancer Medicine The University of Texas MD Anderson Cancer Center Houston, TX [REGISTER NOW!]( [Prime Education] PRIME Education, LLC 114 5th Ave, 14th Floor New York, NY 10011 (954) 718-6055 | [Contact us]( PRIME is a multi-disciplinary accredited provider of continuing medical education. [Unsubscribe from future emails](lst=NL_Prime_Live_Events) | [Contact us]( | [COVID-19 Resource Center](

Marketing emails from primeinc.org

View More
Sent On

05/11/2024

Sent On

05/11/2024

Sent On

29/10/2024

Sent On

28/10/2024

Sent On

25/10/2024

Sent On

24/10/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.